| (Values in U.S. Thousands) | Nov, 2020 | Aug, 2020 | May, 2020 | Feb, 2020 | Nov, 2019 |
| Sales | 9,910 | 13,530 | 13,180 | 13,430 | 12,190 |
| Sales Growth | -26.76% | +2.66% | -1.86% | +10.17% | +51.62% |
| Net Income | -1,600 | 5,180 | 3,010 | -3,330 | 5,210 |
| Net Income Growth | -130.89% | +72.09% | +190.39% | -163.92% | -69.90% |
Liberty Health Sciences Inc (LHSIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Liberty Health Sciences Inc. is engaged in pharmaceutical grade marijuana production. The Company's principal business activity is the production and distribution of medical cannabis through its wholly owned subsidiary Liberty Health Sciences Florida Ltd. Liberty Health Sciences Inc. is based in Toronto, Canada.
Fiscal Year End Date: 06/30